CASSAVA SCIENCES INC.
25,66
08-ноября-24 09:44:38
15 мин. задержка
Акции
+0,32
+1,26%
Сегодняшний диапазон
24,75 - 26,05
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
21 июн 2021 15:10:00 Источник Nasdaq GlobeNewswire
-
21 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation Conference
17 июн 2021 15:01:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors
14 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
24 май 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer’s disease
10 май 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
27 апр 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
26 апр 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
21 апр 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights
23 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
09 мар 2021 08:00:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the H.C. Wainwright Global Life Sciences Conference
08 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference
23 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
22 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Announces Closing of $200 Million Registered Direct Offering
12 фев 2021 16:08:17 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
10 фев 2021 05:15:06 Источник Nasdaq GlobeNewswire
-
08 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
02 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire
-
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 янв 2021 07:30:00 Источник Nasdaq GlobeNewswire